These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 9586583)
21. Complex pharmacology of natural cannabinoids: evidence for partial agonist activity of delta9-tetrahydrocannabinol and antagonist activity of cannabidiol on rat brain cannabinoid receptors. Petitet F; Jeantaud B; Reibaud M; Imperato A; Dubroeucq MC Life Sci; 1998; 63(1):PL1-6. PubMed ID: 9667767 [TBL] [Abstract][Full Text] [Related]
22. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse. Lay L; Angus JA; Wright CE Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647 [TBL] [Abstract][Full Text] [Related]
23. Importance of the C-1 substituent in classical cannabinoids to CB2 receptor selectivity: synthesis and characterization of a series of O,2-propano-delta 8-tetrahydrocannabinol analogs. Reggio PH; Wang T; Brown AE; Fleming DN; Seltzman HH; Griffin G; Pertwee RG; Compton DR; Abood ME; Martin BR J Med Chem; 1997 Sep; 40(20):3312-8. PubMed ID: 9379452 [TBL] [Abstract][Full Text] [Related]
24. Structure-activity relationships for 1',1'-dimethylalkyl-Delta8-tetrahydrocannabinols. Huffman JW; Miller JR; Liddle J; Yu S; Thomas BF; Wiley JL; Martin BR Bioorg Med Chem; 2003 Apr; 11(7):1397-410. PubMed ID: 12628666 [TBL] [Abstract][Full Text] [Related]
25. Activation of brain prostanoid EP3 receptors via arachidonic acid cascade during behavioral suppression induced by Delta8-tetrahydrocannabinol. Yamaguchi T; Kubota T; Watanabe S; Yamamoto T J Neurochem; 2004 Jan; 88(1):148-54. PubMed ID: 14675158 [TBL] [Abstract][Full Text] [Related]
26. Relative efficacies of cannabinoid CB1 receptor agonists in the mouse brain. Burkey TH; Quock RM; Consroe P; Ehlert FJ; Hosohata Y; Roeske WR; Yamamura HI Eur J Pharmacol; 1997 Oct; 336(2-3):295-8. PubMed ID: 9384246 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological evaluation of halogenated delta 8-THC analogs. Charalambous A; Lin S; Marciniak G; Banijamali A; Friend FL; Compton DR; Martin BR; Makriyannis A Pharmacol Biochem Behav; 1991 Nov; 40(3):509-12. PubMed ID: 1666915 [TBL] [Abstract][Full Text] [Related]
28. Separation of cannabinoid receptor affinity and efficacy in delta-8-tetrahydrocannabinol side-chain analogues. Griffin G; Williams S; Aung MM; Razdan RK; Martin BR; Abood ME Br J Pharmacol; 2001 Jan; 132(2):525-35. PubMed ID: 11159703 [TBL] [Abstract][Full Text] [Related]
29. Comparative autoradiographic and metabolic study of delta8- and delta9-tetrahydrocannabinol in the brain of the marmoset Callithrix jacchus. Erdmann G; Just WW; Thel S; Werner G; Wiechmann M Psychopharmacology (Berl); 1976 May; 47(1):53-8. PubMed ID: 822439 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by delta9-tetrahydrocannabinol (delta9-THC): a putative mechanism of cannabinoid-induced immune modulation. Koh WS; Crawford RB; Kaminski NE Biochem Pharmacol; 1997 May; 53(10):1477-84. PubMed ID: 9260875 [TBL] [Abstract][Full Text] [Related]
31. Dose-dependent effects of Delta9-tetrahydrocannabinol on rates of local cerebral glucose utilization in rat. Freedland CS; Whitlow CT; Miller MD; Porrino LJ Synapse; 2002 Aug; 45(2):134-42. PubMed ID: 12112406 [TBL] [Abstract][Full Text] [Related]
32. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction. Chang MC; Berkery D; Schuel R; Laychock SG; Zimmerman AM; Zimmerman S; Schuel H Mol Reprod Dev; 1993 Dec; 36(4):507-16. PubMed ID: 8305215 [TBL] [Abstract][Full Text] [Related]
33. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Paria BC; Das SK; Dey SK Proc Natl Acad Sci U S A; 1995 Oct; 92(21):9460-4. PubMed ID: 7568154 [TBL] [Abstract][Full Text] [Related]
34. Δ Shang VC; Kendall DA; Roberts RE Biochem Pharmacol; 2016 Nov; 120():63-71. PubMed ID: 27641813 [TBL] [Abstract][Full Text] [Related]
35. Synthesis and pharmacological activity of a phosphate ester of delta8-tetrahydrocannabinol. Yoshimura H; Watanabe K; Oguri K; Fujiwara M; Ueki S J Med Chem; 1978 Oct; 21(10):1079-81. PubMed ID: 569207 [TBL] [Abstract][Full Text] [Related]
36. A novel electrophilic high affinity irreversible probe for the cannabinoid receptor. Morse KL; Fournier DJ; Li X; Grzybowska J; Makriyannis A Life Sci; 1995; 56(23-24):1957-62. PubMed ID: 7776819 [TBL] [Abstract][Full Text] [Related]
37. The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol. Smith FL; Cichewicz D; Martin ZL; Welch SP Pharmacol Biochem Behav; 1998 Jun; 60(2):559-66. PubMed ID: 9632241 [TBL] [Abstract][Full Text] [Related]
38. Δ9-tetrahydrocannabinol and its major metabolite Δ9-tetrahydrocannabinol-11-oic acid as 15-lipoxygenase inhibitors. Takeda S; Jiang R; Aramaki H; Imoto M; Toda A; Eyanagi R; Amamoto T; Yamamoto I; Watanabe K J Pharm Sci; 2011 Mar; 100(3):1206-11. PubMed ID: 20891010 [TBL] [Abstract][Full Text] [Related]
39. Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain. Abood ME; Sauss C; Fan F; Tilton CL; Martin BR Pharmacol Biochem Behav; 1993 Nov; 46(3):575-9. PubMed ID: 8278434 [TBL] [Abstract][Full Text] [Related]
40. Chronic exposure to delta 9-tetrahydrocannabinol fails to irreversibly alter brain cannabinoid receptors. Westlake TM; Howlett AC; Ali SF; Paule MG; Scallet AC; Slikker W Brain Res; 1991 Mar; 544(1):145-9. PubMed ID: 1649662 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]